{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:15:35Z","timestamp":1787314535669,"version":"build-2736575974"},"reference-count":30,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Arthritis and Rheumatism"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/j.semarthrit.2024.152499","type":"journal-article","created":{"date-parts":[[2024,6,28]],"date-time":"2024-06-28T03:00:29Z","timestamp":1719543629000},"page":"152499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study"],"prefix":"10.1016","volume":"68","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7613-4801","authenticated-orcid":false,"given":"Lien","family":"Moreel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albrecht","family":"Betrains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennert","family":"Boeckxstaens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Molenberghs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koen","family":"Van Laere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellen","family":"De Langhe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Vanderschueren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Blockmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.semarthrit.2024.152499_bib0001","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.37715","article-title":"2012 Revised International Chapel Hill consensus conference nomenclature of vasculitides","volume":"65","author":"Jennette","year":"2013","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0002","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.1001\/jama.2016.5444","article-title":"Polymyalgia rheumatica and giant cell arteritis: a systematic review","volume":"315","author":"Buttgereit","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0003","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1016\/S0140-6736(08)61077-6","article-title":"Polymyalgia rheumatica and giant-cell arteritis","volume":"372","author":"Salvarani","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0004","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/s41584-023-00976-8","article-title":"Disease stratification in GCA and PMR: state of the art and future perspectives","volume":"19","author":"Tomelleri","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0005","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.semarthrit.2022.152069","article-title":"Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica \u2013 a systematic review and meta-analysis","volume":"56","author":"Nielsen","year":"2022","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0006","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1097\/MD.0b013e318145275c","article-title":"Development of ischemic complications in patients with giant cell arteritis presenting with apparently isolated polymyalgia rheumatica: study of a series of 100 patients","volume":"86","author":"Hern\u00e1ndez-Rodr\u00edguez","year":"2007","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0007","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(23)01310-7","article-title":"Polymyalgia rheumatica","volume":"402","author":"Esp\u00edgol-Frigol\u00e9","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0008","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105494","article-title":"Epidemiology and predictors of relapse in giant cell arteritis: a systematic review and meta-analysis","volume":"90","author":"Moreel","year":"2023","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0009","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s10067-021-05819-z","article-title":"Long-term glucocorticoid treatment and high relapse rate remain unresolved issues in the real-life management of polymyalgia rheumatica: a systematic literature review and meta-analysis","volume":"41","author":"Floris","year":"2022","journal-title":"Clin Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0010","doi-asserted-by":"crossref","DOI":"10.3390\/jcm11041034","article-title":"Impact of glucocorticoid cumulative doses in a real-life cohort of patients affected by giant cell arteritis","volume":"11","author":"Castan","year":"2022","journal-title":"J Clin Med"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0011","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1097\/BOR.0b013e3282f51031","article-title":"The epidemiology of glucocorticoid-associated adverse events","volume":"20","author":"McDonough","year":"2008","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0012","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2024.105706","article-title":"Corrigendum to \u201cEpidemiology and predictors of relapse in giant cell arteritis: a systematic review and meta-analysis\u201d [Joint Bone Spine 2023;90:105494]","author":"Moreel","year":"2024","journal-title":"Jt Bone Spine"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0013","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1097\/01.md.0000180042.42156.d1","article-title":"Giant cell arteritis: disease patterns of clinical presentation in a series of 240 patients","volume":"84","author":"Gonzalez-Gay","year":"2005","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0014","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1007\/s11845-018-1903-1","article-title":"Differences in clinical manifestations and prognosis of Chinese giant cell arteritis patients with or without polymyalgia rheumatica","volume":"188","author":"Zhang","year":"2019","journal-title":"Ir J Med Sci"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0015","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/030097401753180327","article-title":"Prednisolone maintenance dose in relation to starting dose in the treatment of polymyalgia rheumatica and temporal arteritis. A prospective two-year study in 273 patients","volume":"30","author":"Myklebust","year":"2001","journal-title":"Scand J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0016","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00296-017-3874-3","article-title":"Long-term glucocorticoid treatment in patients with polymyalgia rheumatica, giant cell arteritis, or both diseases: results from a national rheumatology database","volume":"38","author":"Albrecht","year":"2018","journal-title":"Rheumatol Int"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0017","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40744-021-00290-3","article-title":"Treatment patterns, disease burden, and outcomes in patients with giant cell arteritis and polymyalgia rheumatica: a real-world, electronic health record-based study of patients in clinical practice","volume":"8","author":"Craig","year":"2021","journal-title":"Rheumatol Ther"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0018","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1002\/art.21699","article-title":"Repetitive 18F-fluorodeoxyglucose positron emission tomography in giant cell arteritis: a prospective study of 35 patients","volume":"55","author":"Blockmans","year":"2006","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0019","doi-asserted-by":"crossref","first-page":"1908","DOI":"10.1093\/rheumatology\/kex376","article-title":"Use of 18f-fluorodeoxyglucose positron emission tomography in the diagnosis of polymyalgia rheumatica \u2014 a prospective study of 99 patients","volume":"57","author":"Henckaerts","year":"2018","journal-title":"Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0020","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.semarthrit.2019.09.008","article-title":"Characteristics and outcomes of patients with ophthalmologic involvement in giant-cell arteritis: a case-control study","volume":"50","author":"Dumont","year":"2020","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0021","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.3899\/jrheum.151135","article-title":"Risk factors for permanent visual loss in biopsy-proven giant cell arteritis: a study of 339 patients","volume":"43","author":"Liozon","year":"2016","journal-title":"J Rheumatol"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/rmdopen-2022-002866","article-title":"Long delay from symptom onset to first consultation contributes to permanent vision loss in patients with giant cell arteritis: a cohort study","volume":"9","author":"Hemmig","year":"2023","journal-title":"RMD Open"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0023","doi-asserted-by":"crossref","first-page":"keae042","DOI":"10.1093\/rheumatology\/keae042","article-title":"Visual manifestations in giant cell arteritis : identification of risk factors from the ARTESER registry","author":"Molina-collada","year":"2024","journal-title":"Rheumatology"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0024","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jaut.2016.10.002","article-title":"Long-term remission in biopsy proven giant cell arteritis: a retrospective cohort study","volume":"77","author":"Restuccia","year":"2017","journal-title":"J Autoimmun"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0025","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.7326\/M23-0679","article-title":"Association between vascular 18F-fluorodeoxyglucose uptake at diagnosis and change in aortic dimensions in giant cell arteritis","volume":"176","author":"Moreel","year":"2023","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0026","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000003851","article-title":"18 F-fluorodeoxyglucose positron emission tomography and the risk of subsequent aortic complications in giant-cell arteritis","volume":"95","author":"De Boysson","year":"2016","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0027","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.autrev.2017.11.029","article-title":"Large-vessel involvement and aortic dilation in giant-cell arteritis. A multicenter study of 549 patients","volume":"17","author":"de Boysson","year":"2018","journal-title":"Autoimmun Rev"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0028","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1002\/art.23315","article-title":"Development of aortic aneurysm\/dilatation during the followup of patients with giant cell arteritis: a cross-sectional screening of fifty-four prospectively followed patients","volume":"59","author":"Garc\u00eda-Mart\u00ednez","year":"2008","journal-title":"Arthritis Care Res"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0029","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/01.md.0000145366.40805.f8","article-title":"Aortic aneurysm and dissection in patients with biopsy-proven giant cell arteritis from northwestern Spain: a population-based study","volume":"83","author":"Gonzalez-Gay","year":"2004","journal-title":"Medicine"},{"key":"10.1016\/j.semarthrit.2024.152499_bib0030","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.semarthrit.2020.11.003","article-title":"Prevalence and prognostic factors for aortic dilatation in giant cell arteritis \u2013 a longitudinal study","volume":"51","author":"Jud","year":"2021","journal-title":"Semin Arthritis Rheum"}],"container-title":["Seminars in Arthritis and Rheumatism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001392?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0049017224001392?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,17]],"date-time":"2024-09-17T20:13:55Z","timestamp":1726604035000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0049017224001392"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,10]]},"references-count":30,"alternative-id":["S0049017224001392"],"URL":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152499","relation":{},"ISSN":["0049-0172"],"issn-type":[{"value":"0049-0172","type":"print"}],"subject":[],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polymyalgia rheumatica is a risk factor for more recalcitrant disease in giant cell arteritis: A retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"Seminars in Arthritis and Rheumatism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semarthrit.2024.152499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"152499"}}